NCT02256124View on ClinicalTrials.gov

Effect of Lamotrigine on Cognition in NF1

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Neurofibromatosis Type 1
Interventions
DRUG

Lamotrigine

DRUG

Placebo

Trial Locations (3)

B-3000

University Hospital Leuven, Leuven

3015CN

Erasmus Medical Center, Rotterdam

Unknown

Hospital Sant Joan de Deu, Barcelona

Sponsors
All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Hospital Sant Joan de Deu

OTHER

lead

Erasmus Medical Center

OTHER